Wellteq Digital Health Inc. is pleased to announce the that after successfully completing the application process, the Company was approved for quotation on the OTCQB(TM), operated by the OTC Markets Groups.
Wellteq Digital Health Inc. (CSE:WTEQ) (OTCQB:WTEQF), (the “Company” or Wellteq”) is pleased to announce the that after successfully completing the application process, the Company was approved for quotation on the OTCQB(TM), operated by the OTC Markets Groups. The Company’s common shares will begin trading today on the OTCQB at the opening of the market under the stock symbol “WTEQF” and will remain listed on the Canadian Securities Exchange under the ticker symbol “WTEQ”.
Scott Montgomery, CEO, commented, “Up-listing to the OTCQB will enhance our visibility and make the Company accessible to a much broader range of U.S. investors. Trading on the OTCQB is expected to increase liquidity by providing current and potential investors with a transparent and easily accessible trading platform where they can find Real-Time quotes and market information.”
Shares of Wellteq, which previously traded on the OTC(TM) Pink Open Market, will now trade on the OTCQB without any further action required.
The OTCQB Venture is the premier marketplace for companies that are committed to providing a high-quality trading and information experience for their US investors. Qualifying for approval to trade on the OTCQB requires a Company to be current on disclosure obligations and to provide an annual company verification and management certification process. The OTCQB quality standards create a solid baseline of transparency, as well as the technology to improve the information and trading experience for investors.
About Wellteq Digital Health Inc.
Wellteq Digital Health Inc. is a leading provider of corporate wellness solutions developed to provide data-driven personalized health and wellness coaching to engage its users in healthier behaviours. As an enterprise (business-to-business) model, Wellteq currently has two main sectors of customers: employers and insurance companies. Wellteq has secured a large multinational portfolio of customers, including UBS, DBS and Bupa Insurance, and reseller partners, like Willis Towers Watson, Advanced Human Imaging and Garmin. Wellteq is developing its newly acquired Internet of Medical Things (IoMT) platform for virtual care applications which will extend the Wellteq continuum of care from preventative wellness through to virtual healthcare. To learn more, visit http://www.wellteq.co. Wellteq Investor Contact:
Bristol Investor Relations E:
Cautionary Note Regarding Forward-Looking Statements:
This news release contains information or statements that constitute “forward-looking statements.” Such forward lookin g statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements, or developments to differ materially from the anticipated results, performance or achievements expressed or implied by such forward-looking statements. Forward-looking statements are statements that are not historic al facts and are generally, but not always, identified by words such as “expects,” “plans,” “anticipates,” “believes,” “intends,” “estimates,” “projects,” “potential” and similar expressions, or that events or conditions “will,” “would, ” “may,” “could” or “should” occur.
Forward looking information may include, without limitation, statements regarding the operations, business, financial condition, expected financial results, performance, prospects, opportunities, priorities, targets, goals, ongoing obj ectives, milestones, strategies and outlook of Wellteq, and includes statements about, among other things, future developments and the future operations, strengths and strategies of Wellteq. Forward-looking information is provided for t he purpose of presenting information about management’s current expectations and plans relating to the future and readers are cautioned that such statements may not be appropriate for other purposes. These statements should not be read as guarantees of future performance or results.
The forward-looking statements made in this news release are based on management’s assumptions and analysis and other factors that may be drawn upon by management to form conclusions and make forecasts or projections, including management’s experience and assessments of historical trends, current conditions and expected future developments. Although management believes that these assumptions, analyses and assessments are reasonable at the time the statements contained in this news release are made, actual results may differ materially from those projected in any forward-looking statements. Examples of risks and factors that could cause actual results to materially differ from forward-looking statements may include: the timing and unpredictability of regulatory actions; regulatory, legislative, legal or other developments with respect to its operations or business; limited marketing and sales capabilities; early stage of the industry and product development; limited products; reliance on third parties; unfavourable publicity or consumer perception; general economic conditions and financial markets; the impact of increasing competition; the loss of key management personnel; capital requirements and liquidity; access to capital; the timing and amount of capital expenditures; t he impact of COVID-19; shifts in the demand for Wellteq’s products and the size of the market; patent law reform; patent litigation and intellectual property; conflicts of interest; and general market and economic conditions.
The forward-looking information contained in this news release represents the expectations of Wellteq as of the date o f this news release and, accordingly, is subject to change after such date. Readers should not place undue importance on forward-looking information and should not rely upon this information as of any other date. Wellteq undertakes no obligation to update these forward-looking statements in the event that management’s beliefs, estimates or opinions, or other factors, should change.
The CSE has neither approved nor disapproved the contents of this news release.